Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone app with video coaching may boost diabetes self-care

NCT ID NCT07794384

Disease control Sponsor: Fu Jen Catholic University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This trial tests whether a specially designed smartphone app can improve self-management and blood sugar control in adults with type 2 diabetes. Participants use the app for daily tracking, video health lessons, and guidance from a team of doctors, nurses, dietitians, and pharmacists. The study compares their self-efficacy, obstacles to self-care, and metabolic measures like HbA1c and fasting glucose against those receiving routine care. The goal is to see if digital support can make daily diabetes management easier and more effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A researcher-designed smartphone app for diabetes self-management, including video health education and multidisciplinary team support.
What this could lead to
If the app works, it could offer a practical, low-cost way to help people with type 2 diabetes manage their condition better, potentially improving blood sugar control and daily self-care.
What could go wrong
This is a small, early-stage trial with 80 participants, so results may not apply to everyone. The app's success depends on user engagement, and it may not lead to lasting improvements in blood sugar or self-management.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with type 2 diabetes for more than 6 months and Hemoglobin A1c (HbA1c) \> 7.5%. * Having diabetes self-management obstacles. * Aged 18 years or older. * Conscious and able to communicate. * Having a smartphone with internet access. * Willing to participate in the study and provide written informed consent. Exclusion Criteria: * Gestational diabetes mellitus. * Currently taking steroid medications. * Having a severe infection requiring hospitalization within the past 6 months. * Unable to perform self-care independently. * Having participated in or currently participating in an educational program of a similar nature.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Self-management are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Self-management Type 2 diabetes mellitus (T2DM)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.